Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:
Quarterly Earnings
Ola Electric Mobility Q3 (Consolidated YoY)
Loss narrows to Rs 487 crore Vs loss of Rs 564 crore
Revenue sinks 55% to Rs 470 crore Vs Rs 1,045 crore
Precision Wires India Q3 (Standalone YoY)
Profit zooms 98.9% to Rs 37.7 crore Vs Rs 18.95 crore
Revenue jumps 37.2% to Rs 1,347.6 crore Vs Rs 982.3 crore
Azad Engineering Q3 (Consolidated YoY)
Profit spikes 44.3% to Rs 34.5 crore Vs Rs 23.9 crore
Revenue grows 31.7% to Rs 158.7 crore Vs Rs 120.5 crore
Fortis Healthcare Q3 (Consolidated YoY)
Profit slips 21.9% to Rs 193.7 crore Vs Rs 247.9 crore
Revenue jumps 17.5% to Rs 2,265 crore Vs Rs 1,928.3 crore
Other income drops to Rs 8.29 crore Vs Rs 20.9 crore
Exceptional loss stands at Rs 45.91 crore Vs gain of Rs 23.8 crore
Easy Trip Planners Q3 (Consolidated YoY)
Profit sinks 82.6% to Rs 5.85 crore Vs Rs 33.6 crore
Revenue rises 0.7% to Rs 151.7 crore Vs Rs 150.6 crore
Anupam Rasayan India Q3 (Consolidated YoY)
Profit grows 11.8% to Rs 60.6 crore Vs Rs 54.2 crore
Revenue jumps 31.3% to Rs 512.4 crore Vs Rs 390.1 crore
Galaxy Surfactants Q3 (Consolidated YoY)
Profit falls 8.7% to Rs 59 crore Vs Rs 64.6 crore
Revenue soars 27.6% to Rs 1,329.5 crore Vs Rs 1,041.7 crore
GMR Airports Q3 (Consolidated YoY)
Profit slips 13.9% to Rs 174 crore Vs Rs 202.1 crore
Revenue zooms 50.5% to Rs 3,994 crore Vs Rs 2,653.2 crore
Shakti Pumps India Q3 (Consolidated YoY)
Profit tanks 69.5% to Rs 31.7 crore Vs Rs 104 crore
Revenue falls 15.1% to Rs 551 crore Vs Rs 648.8 crore
KFin Technologies Q3 (Consolidated YoY)
Profit rises 2% to Rs 92 crore Vs Rs 90.2 crore
Revenue soars 27.9% to Rs 370.9 crore Vs Rs 290 crore
Labour code impact stands at Rs 8.5 crore Vs Nil
Gujarat Mineral Development Corporation Q3 (Consolidated YoY)
Profit declines 10% to Rs 133 crore Vs Rs 147.7 crore
Revenue falls 11.4% to Rs 579.2 crore Vs Rs 653.4 crore
Akums Drug and Pharmaceuticals Q3 (Consolidated YoY)
Profit increases 1.7% to Rs 66.3 crore Vs Rs 65.2 crore
Revenue jumps 14.8% to Rs 116 crore Vs Rs 101 crore
Other income jumps to Rs 34.3 crore Vs Rs 14.5 crore
Exceptional loss stands at Rs 18.2 crore Vs gain of Rs 4.7 crore
National Fertilizers Q3 (Consolidated YoY)
Profit zooms 195.1% to Rs 135.2 crore Vs Rs 45.8 crore
Revenue grows 17.3% to Rs 6,869.8 crore Vs Rs 5,855.9 crore
Inox Green Energy Services Q3 (Consolidated YoY)
Profit spikes 6-fold to Rs 24.7 crore Vs Rs 4.11 crore
Revenue jumps 33.8% to Rs 81.8 crore Vs Rs 61.1 crore
Other income more than doubled to Rs 29.9 crore Vs Rs 12.9 crore
NBCC India Q3 (Consolidated YoY)
Profit soars 39.4% to Rs 193 crore Vs Rs 138.5 crore
Revenue rises 7.6% to Rs 3,022.4 crore Vs Rs 2,809 crore
Exceptional gains stand at Rs 80.1 crore Vs Nil
CRISIL Q3 (Consolidated YoY)
Profit increases 7.5% to Rs 241.5 crore Vs Rs 224.7 crore
Revenue jumps 18.5% to Rs 1,081.6 crore Vs Rs 912.9 crore
Board recommends final dividend of Rs 28 per share
Tilaknagar Industries Q3 (Consolidated YoY)
Loss stands at Rs 105 crore Vs profit of Rs 53.9 crore
Revenue surges 80.4% to Rs 1,453 crore Vs Rs 805.3 crore
Exceptional loss stands at Rs 169.4 crore Vs Nil
RHI Magnesita India Q3 (Consolidated YoY)
Profit grows 29.5% to Rs 61.6 crore Vs Rs 47.5 crore
Revenue rises 8% to Rs 1,092 crore Vs Rs 1,010.7 crore
Torrent Pharmaceuticals Q3 (Consolidated YoY)
Profit jumps 26.2% to Rs 635 crore Vs Rs 503 crore
Revenue surges 17.6% to Rs 3,303 crore Vs Rs 2,809 crore
Board announces an interim dividend of Rs 29 per share
IRB Infrastructure Developers Q3 (Consolidated YoY)
Profit sinks 96.5% to Rs 210.8 crore Vs Rs 6,026.1 crore
Revenue declines 7.6% to Rs 1,871.2 crore Vs Rs 2,025.4 crore
Exceptional loss stands at Rs 42.6 crore Vs gain of Rs 5,804.1 crore
EPL Q3 (Consolidated YoY)
Profit drops 12.6% to Rs 81.7 crore Vs Rs 93.5 crore
Revenue jumps 13.3% to Rs 1,148.8 crore Vs Rs 1,014.3 crore
Exceptional loss stands at Rs 12 crore Vs Nil
Tax expenses jump to Rs 23.7 crore Vs Rs 6.4 crore
Stocks to Watch
The Reserve Bank of India (RBI) has granted its final approval for the proposed acquisition of control and shareholding of up to 41.66% of the paid-up equity capital/convertible instruments of Manappuram Finance by BC Asia Investments XXV and BC Asia Investments XIV.
The company has entered into a Share Purchase Agreement to acquire an 80% stake in Solidrise Realty (SRPL) for Rs 294 crore. Following this, SRPL will become a subsidiary of the company. SRPL is engaged in the real estate business in Pune.
The company has received a Letter of Award from Oil India for the hiring of a 1,000 HP mobile drilling rig package in Assam and Arunachal Pradesh. The total estimated value of the award is approximately Rs 148 crore.
The company has received a Letter of Acceptance from the Ministry of Public Works, Liberia, for a project worth $45.27 million. The project involves upgrading the road from Nrowkia (Sasstown Junction) to Barclayville, Nrowkia (Sasstown Junction) to Sasstown, and part of the Nrowkia (Sasstown Junction) to Nipleppo road project in the Republic of Liberia.
The company’s subsidiary, Acrotech Biopharma Inc., announced that the US Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ADQUEY (difamilast 1%) ointment. ADQUEY is used for the topical treatment of mild-to-moderate atopic dermatitis (AD) in adults and pediatric patients aged two years and older.
The company has received approval for Semaglutide from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market generic Semaglutide injection in India. Natco will launch the product in the Indian market in March 2026.
Semaglutide is used for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.
Jubilant HollisterStier General Partnership (JHSGP) said that the United States Food and Drug Administration (USFDA) has determined the inspection classification for the contract manufacturing facility in Montreal, Canada (CMO Montreal), as Official Action Indicated (OAI). This follows the audit of CMO Montreal conducted in October and November 2025.
The audit was reported by the company on November 4, 2025. Since then, JHSGP has been working closely with the USFDA and is committed to addressing the audit observations.
Following the implementation of robust remediation measures, production operations have resumed at the facility in Q4FY26.
JHSGP is jointly owned by subsidiaries of Jubilant Pharma, a wholly owned subsidiary of the company.
The United States Food and Drug Administration (USFDA) has completed a pre-approval inspection (PAI) at the manufacturing facility of the company’s subsidiary, Enzene Biosciences. At the conclusion of the inspection, the USFDA issued a Form 483 with six procedural observations.
Enzene has achieved zero observations related to data integrity—a critical validation of Enzene’s quality systems and the reliability of regulatory filings.
The company has received final approval from the United States Food and Drug Administration (USFDA) for Ammonium Lactate Cream, 12%.
Ammonium lactate cream, 12%, is a topical prescription medication indicated for the treatment of dry, scaly skin (xerosis) and an inherited dry skin condition called ichthyosis vulgaris. It is used to moisturise the skin by increasing hydration and, as an alpha-hydroxy acid, helps relieve itching, soften the skin, and decrease skin scaling.
The company has inked an agreement to form a joint venture with RMZ, a leading developer and asset manager of commercial real estate, to develop a mixed-use project comprising office buildings, hotels, and retail spaces on the Southern Peripheral Road (SPR) in Gurugram.
Under the agreement, Signature Global and RMZ will form a 50:50 joint venture, with RMZ committing an investment of Rs 1,283 crore to acquire a 50% equity stake in the project.
Under the Securities Subscription and Purchase Agreement, RMZ will acquire a 50% equity stake in Gurugram Commercity through a combination of share purchase and share subscription for Rs 1,283 crore.
The Government of Jharkhand has issued a demand notice for the recovery of a compensation amount of Rs 929.4 crore from Hindustan Copper, alleging that the company undertook production from the Surda mine without valid statutory clearances or in excess of permissible limits during the period from FY2000-01 to FY2016-17.
The company denies the allegations and is taking appropriate legal actions in this regard.
The company’s subsidiary, Horizon Aero Solutions, has completed the acquisition of 100% shareholding in Indamer Technics for Rs 330 crore. Indamer Technics has become a step-down subsidiary of the company.
The acquisition aims to expand the company’s footprint in the aircraft services and MRO industry.
The boards of Religare Enterprises and Religare Finvest have approved a demerger that will segregate the company’s financial services and insurance businesses into two independent listed entities.
Under the proposed scheme of arrangement, Religare Enterprises will retain its stake in Care Health Insurance (CHIL), which will continue as an insurance-focused entity. The financial services business, comprising lending activities, broking activities, investment activities, and ancillary and support services, will be transferred to Religare Finvest on a going-concern basis.
Religare Finvest will issue fully paid-up equity shares to Religare Enterprises shareholders on a 1:1 basis. Post-demerger, Religare Finvest’s shareholding pattern will mirror Religare Enterprises’ pre-demerger shareholding.
The company has signed a Memorandum of Understanding (MoU) with National Aluminium Company (NALCO) to strengthen collaboration in the development of thermal and renewable energy projects.
Bulk Deals
S Gupta Holding has bought 2.75 lakh shares in PVC pipes maker Apollo Pipes at Rs 317.1 per share and 2.5 lakh shares at Rs 317 per share, amounting to a 1.19% stake worth Rs 16.64 crore.
Further, promoter entity S Gupta Holding picked up 3 lakh shares (equivalent to 0.53% of paid-up equity) in SG Finserve, a non-banking finance company, at Rs 408.26 per share for Rs 12.24 crore.
Mercer QIF Fund Plc - Mercer Investment Fund 1, managed by Mercer Global Investments Management, sold 19.04 lakh shares (a 0.58% stake) in Honasa Consumer, the parent company of Mamaearth, at Rs 308.91 per share for Rs 58.82 crore.
Mainboard Listing
Fractal Analytics
Aye Finance
Stocks Trade Ex-Dividend
Apollo Hospitals Enterprise
Escorts Kubota
IIFL Capital Services
Kirloskar Ferrous Industries
Kewal Kiran Clothing
Saven Technologies
Aarti Pharmalabs
Kesar Terminals & Infrastructure
Torrent Power
Uniparts India
Stocks Trade Ex-Date for Income Distribution
Anantam Highways Trust
IRB InvIT Fund
Stock Trades Ex-Date for Rights
Onelife Capital Advisors
Stocks in F&O ban
SAIL
Sammaan Capital
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
